A grant to develop new endovascular nerve stimulation technology for neuropathic pain has been awarded by the National Institutes of Health to a team of multi-institutional researchers including Sunil A. Sheth, MD, of The University of Texas Health Science Center at Houston (UTHealth).
UTHealth welcomed seven new members to its Development Board during a meeting and reception on Tuesday, Oct. 15, at the Briar Club. The new board members are Robert Christopher “Chris” Bell, Mary M. Dyer, Ronald C. Green, Anne L. Hamman, Julia P. Samson, Lisa A. Sarvadi, and Jay S. Zeidman.
An elder abuse team at UTHealth is partnering with the Texas Department of Family and Protective Services, district attorneys, law enforcement agencies, and forensic accounting professionals to make it easier to identify and prosecute individuals who prey on senior citizens to exploit them financially.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at UTHealth as part of a global Phase II clinical trial.
Brigitte Grant, a philanthropic strategist with more than 20 years of experience in fundraising, leadership, and team development, has been named associate vice president for development at UTHealth.
UTHealth is launching a new academic institute to advance clinical care, provide innovative solutions, and improve outcomes for patients of all ages with pediatric and congenital heart defects. Formed in close collaboration with Memorial Hermann Health System, the institute will leverage the expertise of faculty within UTHealth’s six schools as well as its medical practice, UT Physicians.
More headlines »